Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T16:35:53.828Z.
Calculation as of: 2026-10-06T16:35:53.828Z.
Quote observation: 2026-10-06T16:34:32.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b47096c20191003074eea3dc75a1498d2bed5743fa2797f84e024bc92f81a74c
PE RATIO
N/A
PE RATIO AVG TTM
N/A
PE RATIO AVG 3Y
N/A
PE RATIO AVG 5Y
N/A
PE RATIO AVG 10Y
N/A
PE RATIO AVG 15Y
N/A
PE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Biofrontera Inc. (BFRI) | $11.40M | N/A | N/A | N/A | N/A |
| Pluri Inc. (PLUR)vs › | $11.54M | N/A | N/A | N/A | N/A |
| Phio Pharmaceuticals Corp. (PHIO)vs › | $11.58M | N/A | N/A | N/A | N/A |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.61M | N/A | 2.43 | 2.43 | 2.43 |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $11.66M | N/A | N/A | N/A | N/A |
| BioVie Inc. (BIVI)vs › | $11.12M | N/A | N/A | N/A | N/A |
| Caring Brands, Inc. (CABR)vs › | $11.09M | N/A | N/A | N/A | N/A |
| Cerenome, Inc. (CNSY)vs › | $11.01M | N/A | N/A | N/A | N/A |
| Polyrizon Ltd. (PLRZ)vs › | $10.65M | N/A | N/A | N/A | N/A |
| IRIDEX Corporation (IRIX)vs › | $12.20M | N/A | 245.86 | 105.92 | 78.24 |
Trailing P/E
N/A
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$0.89
Forward EPS (Est.)
$-0.39
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PE RATIO |
|---|---|
| 2023-05-12 | 6.50 |
| 2023-05-11 | 9.11 |
| 2023-05-10 | 9.61 |
| 2023-05-09 | 9.65 |
| 2023-05-08 | 9.68 |
| 2023-05-05 | 9.65 |
| 2023-05-04 | 9.60 |
| 2023-05-03 | 9.23 |
| 2023-05-02 | 9.60 |
| 2023-05-01 | 9.24 |
| 2023-04-28 | 9.52 |
| 2023-04-27 | 9.52 |
| 2023-04-26 | 9.03 |
| 2023-04-25 | 9.55 |
| 2023-04-24 | 9.23 |
| 2023-04-21 | 10.08 |
| 2023-04-20 | 9.68 |
| 2023-04-19 | 9.84 |
| 2023-04-18 | 9.84 |
| 2023-04-17 | 9.60 |
| 2023-04-14 | 9.60 |
| 2023-04-13 | 9.58 |
| 2023-04-12 | 9.60 |
| 2023-04-11 | 9.68 |
| 2023-04-10 | 9.47 |
| 2023-04-06 | 9.68 |
| 2023-04-05 | 9.84 |
| 2023-04-04 | 10.45 |
| 2023-04-03 | 10.13 |
| 2023-03-31 | 9.84 |
| 2023-03-30 | 9.68 |
| 2023-03-29 | 9.52 |
| 2023-03-28 | 9.35 |
| 2023-03-27 | 9.68 |
| 2023-03-24 | 10.00 |
| 2023-03-23 | 9.48 |
| 2023-03-22 | 9.77 |
| 2023-03-21 | 10.02 |
| 2023-03-20 | 10.11 |
| 2023-03-17 | 10.48 |
| 2023-03-16 | 10.18 |
| 2023-03-15 | 10.10 |
| 2023-03-14 | 10.06 |